UroGen Pharma Ltd. CEO Elizabeth Barrett's 2022 pay falls 56% to $1.9M
UroGen Pharma Ltd. reports 2022 executive compensation
By ExecPay News
Published: August 1, 2023
UroGen Pharma Ltd. reported fiscal year 2022 executive compensation information on August 1, 2023.
In 2022, three executives at UroGen Pharma Ltd. received on average a compensation package of $1.2M, a 55% decrease compared to previous year.
Average pay of disclosed executives at UroGen Pharma Ltd.
Elizabeth Barrett, Chief Executive Officer, received $1.9M in total, which decreased by 56% compared to 2021. 41% of Barrett's compensation, or $764K, was in salary. Barrett also received $307K in non-equity incentive plan, $753K in option awards, as well as $46K in other compensation.
Jason Smith, General Counsel, received a compensation package of $926K, which decreased by 13% compared to previous year. 48% of the compensation package, or $440K, was in salary.
Don Kim, Chief Financial Officer, earned $738K in 2022.
Related executives
You may also like
Source: SEC filing on August 1, 2023.